Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Rises By 359.0%

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 344,075 shares, a growth of 359.0% from the July 30th total of 74,962 shares. Based on an average daily trading volume, of 3,043,455 shares, the short-interest ratio is currently 0.1 days. Approximately 3.5% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

FEED has been the topic of several research reports. Wall Street Zen upgraded shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Sunday, July 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research note on Tuesday, July 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Nanovibronix presently has an average rating of “Sell”.

Nanovibronix Stock Up 0.8%

Nanovibronix stock traded up $0.00 during midday trading on Wednesday, hitting $0.39. 37,925 shares of the stock were exchanged, compared to its average volume of 5,333,309. Nanovibronix has a 52-week low of $0.29 and a 52-week high of $17.40. The business’s 50-day moving average price is $0.46 and its 200-day moving average price is $1.24. The stock has a market capitalization of $4.30 million, a price-to-earnings ratio of -0.04 and a beta of 1.38.

Nanovibronix (NASDAQ:FEED) last issued its quarterly earnings results on Monday, August 17th. The company reported ($1.98) EPS for the quarter. Nanovibronix had a negative net margin of 1,093.61% and a negative return on equity of 60.73%. The business had revenue of $0.24 million for the quarter.

Insider Activity at Nanovibronix

In other news, insider Christian Michael Glibert sold 210,000 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 12.20% of the company’s stock.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.